Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPower Life Sciences Inc.
About this trial
Clinical trial participation has always been substantially skewed toward certain demographic groups. However, there has been little study on whether trial qualities impact participation in either a positive or negative way. The goal of this research is to identify the characteristics that consistently restrict patients' ability to participate in or complete a trial in which they were initially interested. This data will be analyzed via a number of demographic lenses in order to find trends that could benefit future ALS sufferers.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Lives in the United States
Is 18+ years old
Participant has a diagnosis of Amyotrophic Lateral Sclerosis (ALS)
Participant has enrolled in an interventional clinical for ALS (self-reported)
Disqualifiers
Inability to perform regular electronic reporting
Patient does not understand, sign, and return consent form
No diagnosis of Amyotrophic Lateral Sclerosis (ALS) confirmed
Trial population
Amyotrophic Lateral Sclerosis patients who are actively considering enrolling in an interventional clinical trial, but have not yet completed enrollment and registration.
Trial design
Design model
Case-crossover
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Number of patient decides to enroll in clinical trial
Time frame
3 months2
Rate of patients who remain in clinical trial to trial completion
Time frame
12 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: